BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases. J Neurochem 2019;151:397-416. [PMID: 30474862 DOI: 10.1111/jnc.14635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed SA, Xing XL, Liao QB, Li ZQ, Li CY, Xi K, Wang K, Xia XH. Study on Ammonia Content and Distribution in the Microenvironment Based on Covalent Organic Framework Nanochannels. Anal Chem 2022. [PMID: 35917478 DOI: 10.1021/acs.analchem.2c01692] [Reference Citation Analysis]
2 Faldu KG, Shah JS. Alzheimer's disease: a scoping review of biomarker research and development for effective disease diagnosis. Expert Rev Mol Diagn 2022. [PMID: 35855631 DOI: 10.1080/14737159.2022.2104639] [Reference Citation Analysis]
3 Margiana R, Hammid AT, Ahmad I, Alsaikhan F, Turki Jalil A, Tursunbaev F, Umar F, Romero Parra RM, Fakri Mustafa Y. Current Progress in Aptasensor for Ultra-Low Level Monitoring of Parkinson's Disease Biomarkers. Crit Rev Anal Chem 2022;:1-16. [PMID: 35754381 DOI: 10.1080/10408347.2022.2091920] [Reference Citation Analysis]
4 Kangas SM, Teppo J, Lahtinen MJ, Suoranta A, Ghimire B, Mattila P, Uusimaa J, Varjosalo M, Katisko J, Hinttala R. Analysis of human brain tissue derived from DBS surgery. Transl Neurodegener 2022;11:22. [PMID: 35418104 DOI: 10.1186/s40035-022-00297-y] [Reference Citation Analysis]
5 Neagu A, Jayathirtha M, Baxter E, Donnelly M, Petre BA, Darie CC. Applications of Tandem Mass Spectrometry (MS/MS) in Protein Analysis for Biomedical Research. Molecules 2022;27:2411. [DOI: 10.3390/molecules27082411] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Biswas S, Lan Q, Li C, Xia XH. Morphologically Flex Sm-MOF Based Electrochemical Immunosensor for Ultrasensitive Detection of a Colon Cancer Biomarker. Anal Chem 2022. [PMID: 35119821 DOI: 10.1021/acs.analchem.1c05538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
7 Agrawal I, Tripathi P, Biswas S. Mass Spectrometry Based Protein Biomarkers and Drug Target Discovery and Clinical Diagnosis in Age-Related Progressing Neurodegenerative Diseases. Drug Metab Rev 2022;:1-17. [PMID: 35038284 DOI: 10.1080/03602532.2022.2029475] [Reference Citation Analysis]
8 Xu MM, Zhou MT, Li SW, Zhen XC, Yang S. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach. J Neurosci Res 2021;99:1308-24. [PMID: 33634546 DOI: 10.1002/jnr.24805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Krokidis MG, Exarchos TP, Vlamos P. Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression. Math Biosci Eng 2021;18:1813-32. [PMID: 33757212 DOI: 10.3934/mbe.2021094] [Reference Citation Analysis]
10 Ikonomidou C. Cerebrospinal Fluid Biomarkers in Childhood Leukemias. Cancers (Basel) 2021;13:438. [PMID: 33498882 DOI: 10.3390/cancers13030438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E. Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites. Crit Rev Clin Lab Sci 2021;58:167-79. [PMID: 33137264 DOI: 10.1080/10408363.2020.1833298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Merone GM, Tartaglia A, Locatelli M, D’ovidio C, Rosato E, de Grazia U, Santavenere F, Rossi S, Savini F. Analytical Chemistry in the 21st Century: Challenges, Solutions, and Future Perspectives of Complex Matrices Quantitative Analyses in Biological/Clinical Field. Analytica 2020;1:44-59. [DOI: 10.3390/analytica1010006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Rayaprolu S, Higginbotham L, Bagchi P, Watson CM, Zhang T, Levey AI, Rangaraju S, Seyfried NT. Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau. Neuropsychopharmacology 2021;46:98-115. [PMID: 32898852 DOI: 10.1038/s41386-020-00840-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
14 Korecka JA, Thomas R, Christensen DP, Hinrich AJ, Ferrari EJ, Levy SA, Hastings ML, Hallett PJ, Isacson O. Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblasts. Hum Mol Genet 2019;28:3232-43. [PMID: 31261377 DOI: 10.1093/hmg/ddz126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
15 Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, Mattsson N, Andreasson U, Portelius E, Ashton NJ, Blennow K, Schöll M, Paterson RW, Schott JM, Zetterberg H. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg. Alzheimers Res Ther 2020;12:20. [PMID: 32111242 DOI: 10.1186/s13195-020-00586-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
16 Cookson MR. Proteomics: techniques and applications in neuroscience. J Neurochem 2019;151:394-6. [PMID: 31625157 DOI: 10.1111/jnc.14867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]